Clinical trial of Lando artificial dermis + vacuum sealing drainage technology + autologous split thickness skin in the repair of bone and tendon exposed wounds

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048424

Enrollment

Unknown

Registered

2021-07-06

Start date

2021-07-05

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Tendon exposure group:Lando artificial dermis + negative pressure sealing and drainage technology + autologous blade-thickness skin

Bone exposure group:Lando artificial dermis + negative pressure sealing and drainage technology + autologous blade-thickness skin

Tendon combined with bone exposure group:Lando artificial dermis + negative pressure sealing and drainage technology + autologous blade-thickness skin

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Signed the informed consent to participate in this study; 2. Bone or tendon exposure wound; 3. Chinese patients under the age of 18, no gender limit.

Exclusion criteria

Exclusion criteria: Patients with purulent osteomyelitis, sepsis, severe malnutrition, uncorrected anemia and other systemic factors that affect wound healing.

Design outcomes

Primary

Measure	Time frame
Exposed area of bone or tendon;Number of Lando artificial dermis implantation;Time interval between artificial dermis implantation and secondary skin grafting;Survival rate of secondary skin grafting;Total wound healing time;Scar;	—

Countries

China

Contacts

Public ContactJin Fei

National Center of Children's Health,Beijing/Children Hospital,Capital Medical University

m13241250483@163.com+86 13241250483

Outcome results